Tag

Tag: Antibody-drug conjugates

synaffix adc antibody-drug conjugate glythera

07/01/2020 2 mins

Update: Chinese Pharma Enlists Synaffix’s ADC Technology for Second Drug

adc therapeutics antibody-drug conjugates blood cancer

09/07/2019 2 mins

Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy

Basel 2018 - Ulf Grawunder - Immuno-oncology

25/10/2018 5 mins

Mastering the Competitive World of Immuno-oncology

29/06/2018 2 mins

Update: Yet Another ADC Company Makes Bank, This Time in Series B

11/12/2017 2 mins

New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients

21/11/2017 1 min

German Biotech Reels in €34M for its Cancer-Killing Technology

04/10/2017 5 mins

4th-Generation ADCs: Meet the Swiss Startup Perfecting the Technology

synaffix adc antibody-drug conjugate glythera

20/09/2017 1 min

New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer

16/06/2017 2 mins

Swiss ADCs Show Impressive Responses for Lymphoma in Phase I

01/06/2017 3 mins

Next-Gen Drug Conjugates Bank €46M in Series B with American Investors

24/02/2017 5 mins

What are the Current Challenges in the Booming Field of ADCs?

23/02/2017 4 mins

In the Age of Biological Therapeutics, Chemists move to ADCs